Why Focus on Oral Drugs?
Compelling market opportunities
- Therapeutic areas with large underserved patient populations
- Strong attraction to major pharmas to expand markets for, and extend patent lives of existing drugs
Therapeutic peptides and proteins
- Lower toxicology and safety issues compared to small molecules
- Oral delivery enhances existing drug products